Policy & Regulation
Novotech to acquire Agilex Biolabs from Healius
25 September 2026 - Novotech, a clinical research organisation (CRO) and scientific advisory company, announced on Friday that it has agreed to acquire Agilex Biolabs, a specialist bioanalytical labor...
ACROBiosystems launches CHO-Direct and ACRO AIx to accelerate AI-driven drug discovery
25 September 2026 - US biotechnology company ACROBiosystems on Thursday unveiled its latest innovation portfolio, featuring ACRO AIx, CHO-Direct and GlobalLifeShip cross border supply chain to respond...
UChicago Medicine completes construction phase of new cancer facility
25 September 2026 - The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.Scheduled to open in April 2027 on UChica...
REGENXBIO reports positive three-year durability data for surabgene lomparvovec in diabetic retinopathy
25 September 2026 - Biotechnology company REGENXBIO Inc (Nasdaq:RGNX) on Thursday announced positive long-term follow-up data from the Phase II ALTITUDE study of investigational surabgene lomparvovec ...
Viking Therapeutics plans offerings of common stock and convertible senior notes
24 September 2026 - Viking Therapeutics Inc (Nasdaq:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced on ...
Astellas doses first patient in Phase 3 lung cancer study
24 September 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) announced on Wednesday that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, inv...